Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects
NCT01435915
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Ropinirole
Sponsor
GlaxoSmithKline